Advancing coagulation diagnostics with ZELLCLOT, launched at GAPM 2026

A landmark achievement for the IVD industry, ZELLCLOT represents India’s first USFDA-approved coagulation solution manufactured under the Make in India initiative.
Developed in alignment with global regulatory and quality standards, ZELLCLOT reflects a significant step forward in India’s capability to deliver world-class diagnostic solutions.
Engineered for precision, accuracy, and reproducibility, ZELLCLOT is designed to meet the rigorous demands of modern clinical laboratories. Its consistent performance supports reliable coagulation testing, enabling clinicians and laboratories to make confident diagnostic and therapeutic decisions.
The successful USFDA approval underscores ZELLCLOT’s compliance with international benchmarks for quality, safety, and performance. Manufactured in India with advanced processes and stringent quality controls, ZELLCLOT combines global standards with local innovation—strengthening India’s position as a trusted contributor to the global IVD landscape.
With ZELLCLOT, we reaffirm our commitment to innovation, quality, and reliability, delivering coagulation solutions that meet the evolving needs of laboratories in India and across international markets.
is designed to meet the rigorous demands of modern clinical laboratories. Its consistent performance supports reliable coagulation testing, enabling clinicians and laboratories to make confident diagnostic and therapeutic decisions.
The successful USFDA approval underscores ZELLCLOT’s compliance with international benchmarks for quality, safety, and performance. Manufactured in India with advanced processes and stringent quality controls, ZELLCLOT combines global standards with local innovation—strengthening India’s position as a trusted contributor to the global IVD landscape.
With ZELLCLOT, we reaffirm our commitment to innovation, quality, and reliability, delivering coagulation solutions that meet the evolving needs of laboratories in India and across international markets.

